Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,473
Total Claims
$578K
Drug Cost
687
Beneficiaries
$841
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+20%
Opioid rate vs peers
3.1% vs 2.6% avg
-21%
Cost per patient vs peers
$841 vs $1,068 avg
+42%
Brand preference vs peers
12.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.1%
Opioid Rate
292
Opioid Claims
$2,663
Opioid Cost
4.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,205 claims · $372K
Generic: 8,215 claims · $204K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 77 | $71K |
| Tiotropium Bromide | 69 | $36K |
| Dapagliflozin Propanediol | 31 | $26K |
| Mirabegron | 36 | $23K |
| Apixaban | 38 | $21K |
| Budesonide/Formoterol Fumarate | 46 | $19K |
| Fluticasone Propionate | 47 | $14K |
| Levothyroxine Sodium | 755 | $14K |
| Empagliflozin | 14 | $12K |
| Atorvastatin Calcium | 536 | $11K |
| Sumatriptan Succinate | 33 | $9,197 |
| Tiotropium Bromide | 12 | $7,299 |
| Valsartan | 108 | $7,225 |
| Fluticasone Propion/Salmeterol | 16 | $6,871 |
| Fluticasone Propion/Salmeterol | 23 | $6,765 |
Prescribing Profile
Patient Profile
76
Avg Age
75%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About